CardioVascular BioTherapeutics (fka CVBT)

[walhall]

2021: The Great Reveal

2021 was the year where everything the naysayers have been saying was proven true. In April 2021, Venturis Therapeutics' long time counsel, Dentons, withdrew from representing the company. Dentons claimed in a court filing that Venturis had no ability to pay the $200,000+ it was owed, had no revenues, and no assets of value.

Here is the court filing:

DECLARATION OF BARRY F. CANNADAY IN SUPPORT OF MOTION TO WITHDRAW

I, Barry F. Cannaday, declare as follows in support of this Motion to Withdraw as an Attorney for Venturis Therapeutics, Inc. (“Venturis”) in the matter styled Daniel C. Montano and Dr. John W. Jacobs vs. Venturis Therapeutics, Inc., Case No. 2:20-cv-01410-GMN-BNW originally filed in the United States District Court for the District of Nevada, but which was closed on January 21, 2021 (the “Previously Closed Case”):

1. I am an attorney duly licensed to practice before all Courts in the State of Texas and I was admitted to practice Pro Hac Vice in the Previously Closed Case on behalf of Venturis on August 18, 2020. I have been a partner in the law firm of Dentons US, LLP since 2009.

2. Venturis initially agreed to retain Barry F. Cannaday in connection with the arbitration that was filed by Venturis against Mr. Montano and Dr. Jacobs (“Counter-Claimants”) on July 19, 2018. Following the issuance of the Arbitrator’s Final Award in that Arbitration on July 20, 2020, Counter-Claimants filed an Application for Order Confirming Arbitration Award in this Court on July 29, 2020. Barry F. Cannaday agreed to continue to represent Venturis in connection with the proceedings in this Court relating to Counter-Claimants attempts to confirm the Arbitration Award. This Court confirmed the Arbitration Award on January 25, 2021 and this case was thereafter closed on January 25, 2021.

3. On April 8, 2021 counsel for Counter-Claimants provided Barry F. Cannaday with copies of post-judgment Interrogatories and Requests for Production,. However, Barry F. Cannaday has not agreed to represent Venturis in any connection with post-judgment collection matters. Mr. Cannaday considered his representation of Venturis in this matter completed when this case was closed on January 25, 2021.

4. Further, as of March 31, 2021, Venturis owed Mr. Cannaday’s law firm, Dentons US LLP (“Dentons”), unpaid fees in excess of $200,000 for representation in this Previously Closed Case and for representation in the underlying arbitration.

5. Barry F. Cannaday performed his obligations as counsel for Venturis in the Previously Closed Case and in the underlying Arbitration in a skillful and diligent manner. However, Venturis has been rendered incapable of paying Mr. Cannaday’s law firm in accordance with the terms of its agreement.

6. Upon investigation as to Venturis ability to pay legal fees in accordance with its agreement, it has become evident that there are currently no assets or revenue streams from which payments can be made.

7. Barry F. Cannaday and Venturis have maintained a good working relationship throughout these proceedings. As such, the present Motion to Withdraw is not the result of any differences between Barry F. Cannaday and the client, but instead is the result of the inability of Venturis to meet its financial obligations to Dentons.

8. Defendant’s address is: 10455 Markison Road, Dallas, Texas 75238 and Barry F. Cannaday certifies that Venturis will be served with a copy of this Motion to Withdraw.

9. I personally visited with Jon Ross, Secretary and a Member of the Board of Directors of Venturis on Thursday, April 8, 2021 and advised him of my intention to file this notice and motion. Mr. Ross stated that Venturis had no objection to this Motion to Withdraw. I declare under penalty of perjury of the laws of the State of Nevada that the foregoing is true and correct.

Executed this 12th day of April, 2021.
/s/ Barry F. Cannaday
Barry, F. Cannaday, Esq.
DENTONS US LLP
2000 McKinney Ave
Suite 1900
Dallas, Texas 75201
Telephone: [phone]
Facsimile: [phone]

For more information:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=165949650